These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9469489)

  • 1. Successful mycophenolate mofetil treatment of glomerular disease.
    Briggs WA; Choi MJ; Scheel PJ
    Am J Kidney Dis; 1998 Feb; 31(2):213-7. PubMed ID: 9469489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil treatment for primary glomerular diseases.
    Choi MJ; Eustace JA; Gimenez LF; Atta MG; Scheel PJ; Sothinathan R; Briggs WA
    Kidney Int; 2002 Mar; 61(3):1098-114. PubMed ID: 11849465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome.
    Gargah TT; Lakhoua MR
    J Nephrol; 2011; 24(2):203-7. PubMed ID: 21319130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases.
    Appel AS; Appel GB
    Nat Clin Pract Nephrol; 2009 Mar; 5(3):132-42. PubMed ID: 19174771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil in primary glomerulopathies.
    Sepe V; Libetta C; Giuliano MG; Adamo G; Dal Canton A
    Kidney Int; 2008 Jan; 73(2):154-62. PubMed ID: 17989649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of mycophenolic acid in non-transplant renal diseases.
    Stassen PM; Kallenberg CG; Stegeman CA
    Nephrol Dial Transplant; 2007 Apr; 22(4):1013-9. PubMed ID: 17307748
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil treatment for therapy-resistant glomerulopathies.
    Sahin GM; Sahin S; Kantarci G; Ergin H
    Nephrology (Carlton); 2007 Jun; 12(3):285-8. PubMed ID: 17498124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil in the treatment of glomerular diseases.
    Grcevska L; Polenakovic M
    Prilozi; 2007 Jul; 28(1):57-68. PubMed ID: 17921918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus nephritis: treatment with mycophenolate mofetil.
    Kapitsinou PP; Boletis JN; Skopouli FN; Boki KA; Moutsopoulos HM
    Rheumatology (Oxford); 2004 Mar; 43(3):377-80. PubMed ID: 14963204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of mycophenolate mofetil on primary and secondary treatment of primary glomerulonephritis and lupus nephritis.
    Paydas S; Kurt C; Taskapan H; Balal M; Sertdemir Y; Pembegul I
    Int Urol Nephrol; 2009; 41(1):145-52. PubMed ID: 18766457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose mycophenolate mofetil in the treatment of posttransplant glomerular disease in the allograft: a case series.
    Wu J; Jaar BG; Briggs WA; Choi MJ; Kraus ES; Racusen LC; Atta MG; Samaniego MD
    Nephron Clin Pract; 2004; 98(3):c61-6. PubMed ID: 15528938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.
    Karim MY; Pisoni CN; Ferro L; Tungekar MF; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
    Rheumatology (Oxford); 2005 Oct; 44(10):1317-21. PubMed ID: 16049051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome.
    Day CJ; Cockwell P; Lipkin GW; Savage CO; Howie AJ; Adu D
    Nephrol Dial Transplant; 2002 Nov; 17(11):2011-3. PubMed ID: 12401863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mycophenolate mofetil in autoimmune and renal diseases.
    Appel GB; Radhakrishnan J; Ginzler EM
    Transplantation; 2005 Oct; 80(2 Suppl):S265-71. PubMed ID: 16251859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases.
    Kasitanon N; Petri M; Haas M; Magder LS; Fine DM
    Lupus; 2008 Jan; 17(1):40-5. PubMed ID: 18089682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
    Senthil Nayagam L; Ganguli A; Rathi M; Kohli HS; Gupta KL; Joshi K; Sakhuja V; Jha V
    Nephrol Dial Transplant; 2008 Jun; 23(6):1926-30. PubMed ID: 17989103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A; Hari P; Moudgil A; Jordan SC
    Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil treatment in primary glomerular disease: one-year follow-up in steroid dependent and resistant nephrotic syndrome.
    Tasanarong A; Thitiarchakul S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S218-27. PubMed ID: 17044475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil.
    Mogyorósi A; Lippman HR; Feldman GM
    Am J Nephrol; 2002; 22(5-6):569-72. PubMed ID: 12381961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.